Literature DB >> 12538992

Effect of preoperative delay on prognosis for patients with early stage non-small cell lung cancer.

Renée L Quarterman1, Alex McMillan, Mark B Ratcliffe, Mark I Block.   

Abstract

OBJECTIVE: Screening for lung cancer will discover many nodules of indeterminate pathology. Observation has the theoretic risk of permitting dissemination of a localized cancer and worsening prognosis, whereas immediate evaluation of benign conditions generates morbidity and cost. This study was conducted to assess the effect of delay in surgical intervention on survival for patients with early stage non-small cell lung cancer.
METHODS: Records for patients with resected pathologic stage I and II non-small cell lung cancer (1989-1999) were abstracted for patient age, race, sex, medical history, date of presentation, date and type of surgical treatment, pathologic stage, and date of death or last follow-up. Kaplan-Meier survival analysis was performed to test for the effect of delay (time from presentation to surgical intervention) on survival.
RESULTS: Eighty-four patients were identified. Median age was 66 years, median preoperative interval was 82 days (range, 1-641 days), and median follow-up was 3.3 years (range, 5 days-11.9 years). Median survival was 3.7 years. Overall 5-year survival was 40%; disease-specific 5-year survival was 63%. Log-rank analysis of the effect of delay on overall survival generated a P value of.54, with an estimated hazard ratio for a 90-day delay of 1.06 (95% confidence interval, 0.87-1.30).
CONCLUSIONS: For this population, we were unable to detect a significant effect of delay on prognosis. Although these results suggest that the risk of judicious observation of indeterminate pulmonary nodules might be low, the 95% confidence interval is broad. Larger sample sizes are needed to reach definitive conclusions.

Entities:  

Mesh:

Year:  2003        PMID: 12538992     DOI: 10.1067/mtc.2003.93

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  30 in total

1.  Effect of delays on survival in patients with lung cancer.

Authors:  Francisco Javier González-Barcala; José María García-Prim; José Manuel Alvarez-Dobaño; Milagros Moldes-Rodríguez; María Teresa García-Sanz; Antonio Pose-Reino; Luis Valdés-Cuadrado
Journal:  Clin Transl Oncol       Date:  2010-12       Impact factor: 3.405

2.  Implementing effective and sustainable multidisciplinary clinical thoracic oncology programs.

Authors:  Raymond U Osarogiagbon; Richard K Freeman; Mark J Krasna
Journal:  Transl Lung Cancer Res       Date:  2015-08

3.  Diagnostic evaluation following a positive lung screening chest radiograph in the Prostate, Lung, Colorectal, Ovarian (PLCO) Cancer Screening Trial.

Authors:  William G Hocking; Martin C Tammemagi; John Commins; Martin M Oken; Paul A Kvale; Ping Hu; Lawrence R Ragard; Tom L Riley; Paul Pinsky; Thomas M Beck; Philip C Prorok
Journal:  Lung Cancer       Date:  2013-08-07       Impact factor: 5.705

4.  Pathologic Upstaging in Patients Undergoing Resection for Stage I Non-Small Cell Lung Cancer: Are There Modifiable Predictors?

Authors:  Matthew J Bott; Aalok P Patel; Traves D Crabtree; Graham A Colditz; Daniel Kreisel; A Sasha Krupnick; G Alexander Patterson; Stephen Broderick; Bryan F Meyers; Varun Puri
Journal:  Ann Thorac Surg       Date:  2015-08-13       Impact factor: 4.330

5.  Timeliness of Treatment Initiation and Associated Survival Following Diagnosis of Non-Small-Cell Lung Cancer in South Carolina.

Authors:  Jarrod T Bullard; Jan M Eberth; Amanda K Arrington; Swann A Adams; Xi Cheng; Ramzi G Salloum
Journal:  South Med J       Date:  2017-02       Impact factor: 0.954

6.  Saving time is saving lives: a delayed lobectomy predicts poorer overall survival in patients with clinical stage IA squamous cell carcinoma of the lung.

Authors:  Ching Feng Wu; Yin-Kai Chao
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

7.  Delays in the diagnosis of lung cancer.

Authors:  Peter M Ellis; Rachel Vandermeer
Journal:  J Thorac Dis       Date:  2011-09       Impact factor: 2.895

Review 8.  Measuring improvement in populations: implementing and evaluating successful change in lung cancer care.

Authors:  Xinhua Yu; Lisa M Klesges; Mathew P Smeltzer; Raymond U Osarogiagbon
Journal:  Transl Lung Cancer Res       Date:  2015-08

9.  Is it safe to wait? The effect of surgical wait time on survival in patients with non-small cell lung cancer.

Authors:  Shaun Coughlin; Madelaine Plourde; Keegan Guidolin; Dalilah Fortin; Eric Frechette; Richard Malthaner; Richard Inculet
Journal:  Can J Surg       Date:  2015-12       Impact factor: 2.089

10.  Do diagnostic delays in cancer matter?

Authors:  R D Neal
Journal:  Br J Cancer       Date:  2009-12-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.